Principal Financial Group Inc Precision Biosciences Inc Transaction History

Principal Financial Group Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.15 - $3.34 $783,329 - $2.28 Million	-681,156 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$2.96 - $7.76 $1,124 - $2,948	-380 Reduced 0.06%	681,156 $2.1 Million
Q4 2021 Feb 09, 2022	BUY	$7.4 - $11.66 $1.42 Million - $2.24 Million	192,243 Added 39.29%	681,536 $5.04 Million
Q3 2021 Nov 09, 2021	BUY	$9.18 - $14.15 $259,601 - $400,147	28,279 Added 6.13%	489,293 $5.65 Million
Q2 2021 Aug 10, 2021	BUY	$8.07 - $12.52 $339,859 - $527,267	42,114 Added 10.05%	461,014 $5.77 Million
Q1 2021 May 10, 2021	BUY	$8.57 - $15.79 $273,305 - $503,558	31,891 Added 8.24%	418,900 $4.34 Million
Q4 2020 Feb 08, 2021	BUY	$5.98 - $12.47 $101,115 - $210,855	16,909 Added 4.57%	387,009 $3.23 Million
Q3 2020 Nov 06, 2020	BUY	$4.65 - $8.73 $51,150 - $96,030	11,000 Added 3.06%	370,100 $2.28 Million
Q2 2020 Aug 05, 2020	BUY	$4.66 - $8.7 $601,606 - $1.12 Million	129,100 Added 56.13%	359,100 $2.99 Million
Q4 2019 Feb 05, 2020	BUY	$6.32 - $19.66 $382,360 - $1.19 Million	60,500 Added 35.69%	230,000 $3.2 Million
Q3 2019 Nov 13, 2019	BUY	$8.03 - $14.82 $362,466 - $668,959	45,139 Added 36.3%	169,500 $1.42 Million
Q2 2019 Aug 12, 2019	BUY	$11.88 - $16.94 $586,408 - $836,175	49,361 Added 65.81%	124,361 $1.65 Million
Q1 2019 May 10, 2019	BUY	$17.44 - $17.95 $1.31 Million - $1.35 Million	75,000 New	75,000 $1.35 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.